UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.569

Sortiert nach

Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway

Life Sciences, 2020-09, Vol.256, p.117925-117925, Article 117925

2020

Link zum Volltext

Verfügbarkeit prüfen

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)

Supportive care in cancer, 2022-09, Vol.30 (9), p.7047-7051

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study

Endocrine, 2023-10, Vol.82 (1), p.181-189

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways

Cell biology international, 2021-05, Vol.45 (5), p.1015-1029

2021

Link zum Volltext

Verfügbarkeit prüfen

Atypical Cause for Sclerotic Bone Disease

Indian journal of endocrinology and metabolism, 2023-09, Vol.27 (5), p.463-464

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation

International journal of molecular sciences, 2022-05, Vol.23 (11), p.5944

2022

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of zoledronic acid and strontium-89 in treating non–small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

Supportive care in cancer, 2020-07, Vol.28 (7), p.3291-3301

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women

Journal of the College of Physicians and Surgeons--Pakistan, 2021-02, Vol.31 (2), p.240-242

2021

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy

Cancers, 2022-03, Vol.14 (6), p.1560

2022

Link zum Volltext

Verfügbarkeit prüfen

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications

Cells (Basel, Switzerland), 2022-07, Vol.11 (15), p.2308

2022

Link zum Volltext

Verfügbarkeit prüfen

Standardized Arrabidaea chica Extract Shows Cytoprotective Effects in Zoledronic Acid-Treated Fibroblasts and Osteoblasts

Clinical, cosmetic and investigational dentistry, 2020-01, Vol.12, p.327-333

2020

Link zum Volltext

Verfügbarkeit prüfen

Thermodynamic study of the interaction between calcium and zoledronic acid by calorimetry

The Journal of chemical thermodynamics, 2016-06, Vol.97, p.290-296

2016

Link zum Volltext

Verfügbarkeit prüfen

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer

Asian journal of andrology, 2019-01, Vol.21 (1), p.12-18

2019

Link zum Volltext

Verfügbarkeit prüfen

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis

Cancer cell international, 2020-02, Vol.20 (1), p.46-46, Article 46

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of the use of bisphosphonates on the development of postextraction sequelae: scoping review with mapping evidence of in vivo studies

Journal of dentistry, 2024-05, p.105051-105051, Article 105051

2024

Link zum Volltext

Verfügbarkeit prüfen

Potential Anti-Inflammatory Constituents from IAesculus wilsonii/I Seeds

Molecules (Basel, Switzerland), 2024-03, Vol.29 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

A simple RP-HPLC method for related substances of zoledronic acid in pharmaceutical products

Arabian journal of chemistry, 2017-02, Vol.10 (S1), p.S196-S204

2017

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid

Leukemia, 2017-01, Vol.31 (1), p.258-262

2017

Link zum Volltext

Verfügbarkeit prüfen

Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials

Journal of bone oncology, 2013-06, Vol.2 (2), p.70-76

2013

Link zum Volltext

Verfügbarkeit prüfen

PR042: Influence of pH on the growth and activity of osteoclasts treated with zoledronate

Journal of clinical periodontology, 2018-06, Vol.45 (S19), p.133-133

2018

Link zum Volltext

Verfügbarkeit prüfen

PR036: Immunohistochemical analysis of the effects of zoledronic acid on oral mucosa with experimentally induced periodontal destruction

Journal of clinical periodontology, 2018-06, Vol.45 (S19), p.131-131

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model

Journal of ophthalmic & vision research, 2014-01, Vol.9 (1), p.44-49

2014

Link zum Volltext

Verfügbarkeit prüfen

Preparation, Optimisation, and In Vitro Evaluation of [[sup.18]F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET

Molecules (Basel, Switzerland), 2022-11, Vol.27 (22)

2022

Link zum Volltext

Verfügbarkeit prüfen

Paget's disease

Medicine (Abingdon. 1995, UK ed.), 2013-10, Vol.41 (10), p.592-593

Selby, Peter

2013

Link zum Volltext

Verfügbarkeit prüfen

Response to: Prognosis of metastatic bone cancer and myeloma patients and longâterm risk of medicationârelated osteonecrosis of the jaw : some critical points

Supportive care in cancer, 2022-12, Vol.30 (12), p.9693

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.569

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

KollektionTaylor & Francis Online

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.217)
Mit Volltextzugriff
(1.498)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study

Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways

Atypical Cause for Sclerotic Bone Disease

Quantification of Low Amounts of Zoledronic Acid by HPLC-ESI-MS Analysis: Method Development and Validation

The efficacy and safety of zoledronic acid and strontium-89 in treating non–small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials

Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women

Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications

Standardized Arrabidaea chica Extract Shows Cytoprotective Effects in Zoledronic Acid-Treated Fibroblasts and Osteoblasts

Thermodynamic study of the interaction between calcium and zoledronic acid by calorimetry

Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer

Zoledronic acid inhibits TSC2-null cell tumor growth via RhoA/YAP signaling pathway in mouse models of lymphangioleiomyomatosis

Influence of the use of bisphosphonates on the development of postextraction sequelae: scoping review with mapping evidence of in vivo studies

Potential Anti-Inflammatory Constituents from IAesculus wilsonii/I Seeds

A simple RP-HPLC method for related substances of zoledronic acid in pharmaceutical products

Expansion of Th1-like Vγ9Vδ2T cells by new-generation IMiDs, lenalidomide and pomalidomide, in combination with zoledronic acid

Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials

PR042: Influence of pH on the growth and activity of osteoclasts treated with zoledronate

PR036: Immunohistochemical analysis of the effects of zoledronic acid on oral mucosa with experimentally induced periodontal destruction

Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model

Preparation, Optimisation, and In Vitro Evaluation of [[sup.18]F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET

Paget's disease

Response to: Prognosis of metastatic bone cancer and myeloma patients and longâterm risk of medicationârelated osteonecrosis of the jaw : some critical points

Aktive Filter

Suchergebnisse filtern